364 related articles for article (PubMed ID: 3595539)
1. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
2. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
3. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.
Ghatei MA; Uttenthal LO; Christofides ND; Bryant MG; Bloom SR
J Clin Endocrinol Metab; 1983 Sep; 57(3):488-95. PubMed ID: 6874888
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
7. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat.
Fothergill LJ; Ringuet MT; Sioras E; Hunne B; Fazio Coles TE; Martins PR; Furness JB
Cell Tissue Res; 2019 Feb; 375(2):359-369. PubMed ID: 30259122
[TBL] [Abstract][Full Text] [Related]
8. Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney.
Kervran A; Dubrasquet M; Blache P; Martinez J; Bataille D
Regul Pept; 1990 Oct; 31(1):41-52. PubMed ID: 2270317
[TBL] [Abstract][Full Text] [Related]
9. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.
Rodier G; Magous R; Mochizuki T; Martinez J; Nguyen DL; Bali JP; Bataille D; Jarrousse C
Pflugers Arch; 1997 Nov; 434(6):729-34. PubMed ID: 9306005
[TBL] [Abstract][Full Text] [Related]
10. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay.
Munck A; Kervran A; Marie JC; Bataille D; Rosselin G
Peptides; 1984; 5(3):553-61. PubMed ID: 6473171
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-related peptides in the human gastrointestinal mucosa.
Baldissera FG; Holst JJ
Diabetologia; 1984 Mar; 26(3):223-8. PubMed ID: 6546922
[TBL] [Abstract][Full Text] [Related]
14. Purification and sequence of rat oxyntomodulin.
Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic and intestinal processing of proglucagon in man.
Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
[TBL] [Abstract][Full Text] [Related]
16. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro.
Lui EY; Asa SL; Drucker DJ; Lee YC; Brubaker PL
Endocrinology; 1990 Jan; 126(1):110-7. PubMed ID: 2152861
[TBL] [Abstract][Full Text] [Related]
17. [Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].
Bataille D; Tatemoto K; Coudray AM; Rosselin G; Mutt V
C R Seances Acad Sci III; 1981 Oct; 293(6):323-8. PubMed ID: 6797684
[TBL] [Abstract][Full Text] [Related]
18. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
Larsson LI; Moody AJ
J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
[TBL] [Abstract][Full Text] [Related]
19. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
Anini Y; Jarrousse C; Chariot J; Nagain C; Yanaihara N; Sasaki K; Bernad N; Le Nguyen D; Bataille D; Rozé C
Pancreas; 2000 May; 20(4):348-60. PubMed ID: 10824688
[TBL] [Abstract][Full Text] [Related]
20. Oxyntomodulin reduces hydromineral transport through rat small intestine.
Beauclair F; Eto B; Pansu D; Rodier G; Mochizuki T; Martinez J; Bataille D; Jarrousse C
Dig Dis Sci; 1998 Aug; 43(8):1814-23. PubMed ID: 9724174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
